Deciphera Pharmaceuticals, Inc. DCPH
Set alert
25.59 +25.59 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 2.21B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -15.23
- Beta
- 0.18
- Short ratio
- 1.05
- Inst. own
- 72.03%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 10, 2024
- 50-d avg
- 21.67
- 200-d avg
- 15.94
- 1y target
- 27.52
Analyst view
Consensus: hold
Hold
Price target (mean) 27.52 +7.5% upside
Now 25.59
- Target (low)
- 25.60
- Target (mean)
- 27.52
- Target (high)
- 30.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 10
- 2 months ago 11
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.51 | -0.55 – -0.46 | -0.57 | +10.5% | 49.63M | +29.6% | 3 |
| Next quarter | -0.48 | -0.50 – -0.45 | -0.58 | +17.2% | 52.98M | +34.5% | 3 |
| Current year | -1.98 | -2.10 – -1.87 | -2.29 | +13.5% | 204.14M | +25.0% | 3 |
| Next year | -1.68 | -1.79 – -1.59 | -1.98 | +15.2% | 247.06M | +21.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 9, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 9, 2023 | Stifel | Upgrade | Hold | Buy |
| Jun 4, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| May 3, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| Mar 14, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| Feb 7, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 7, 2023 | SVB Leerink | Reiterated | — | Outperform |
| Feb 6, 2023 | SVB Leerink | Maintained | — | Outperform |
| Jan 24, 2023 | Cowen & Co. | Maintained | — | Outperform |
| Jan 5, 2023 | JonesTrading | Upgrade | Sell | Hold |
| Jan 3, 2023 | SVB Leerink | Maintained | — | Outperform |
| Jan 3, 2023 | Barclays | Maintained | — | Underweight |
| Jan 3, 2023 | Guggenheim | Upgrade | Neutral | Buy |
| Sep 26, 2022 | Stifel | Maintained | — | Hold |
| Sep 11, 2022 | SVB Leerink | Maintained | — | Outperform |
| Sep 11, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 28, 2022 | Cowen & Co. | Initiated | — | Outperform |
| Aug 4, 2022 | SVB Leerink | Maintained | — | Outperform |
| Aug 4, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 4, 2022 | JMP Securities | Upgrade | Market Perform | Market Outperform |
| Feb 27, 2022 | Barclays | Downgrade | Equal-Weight | Underweight |
| Nov 30, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 7, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 7, 2021 | Stifel | Downgrade | Buy | Hold |
| Nov 7, 2021 | Barclays | Downgrade | Overweight | Equal-Weight |
| Nov 7, 2021 | Canaccord Genuity | Downgrade | Buy | Hold |
| Nov 7, 2021 | Truist Securities | Downgrade | Buy | Hold |
| Nov 4, 2021 | Truist Securities | Downgrade | Buy | Hold |
| Nov 4, 2021 | JMP Securities | Maintained | — | Market Outperform |
| Aug 3, 2021 | HC Wainwright & Co. | Maintained | — | Buy |